Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

NxThera closes $40mm Series D round

Executive Summary

NxThera Inc. (radiofrequency-based devices for endourological conditions including BPH) raised $40mm through what looks to be its Series D round. Boston Scientific led and was joined by returning backers Aberdare Ventures, Arboretum Ventures, GDN Holdings, and the Ally Bridge Group. The company notes that it also expanded a debt facility with East West Bank.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Radiofrequency Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies